{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:05:21Z","timestamp":1789992321922,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872356"],"award-info":[{"award-number":["81872356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00873-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:16:31Z","timestamp":1782479791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and prognostic analysis of genes related to CTNNB1 mutations in hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Ningqi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zule","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huliang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"873_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"873_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"EASL Clinical Practice Guidelines on the management","year":"2025","unstructured":"EASL Clinical Practice Guidelines on the management. of hepatocellular carcinoma. J Hepatol. 2025;82:315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028.","journal-title":"J Hepatol"},{"key":"873_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s1470-2045(20)30011-5","volume":"21","author":"S Qin","year":"2020","unstructured":"Qin S, Ren Z, Meng Z, et al. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial. Lancet Oncol. 2020;21:571\u201380. https:\/\/doi.org\/10.1016\/s1470-2045(20)30011-5.","journal-title":"Lancet Oncol"},{"key":"873_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/s0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 2017;389:2492\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(17)31046-2.","journal-title":"Lancet"},{"key":"873_CR5","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.28638","volume":"64","author":"S Rebouissou","year":"2016","unstructured":"Rebouissou S, Franconi A, Calderaro J, et al. Genotype-phenotype correlation of CTNNB1 mutations reveals different \u00df\u2010catenin activity associated with liver tumor progression. Hepatology. 2016;64:2047\u201361. https:\/\/doi.org\/10.1002\/hep.28638.","journal-title":"Hepatology"},{"key":"873_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cellsig.2009.11.021","volume":"22","author":"C Gao","year":"2010","unstructured":"Gao C, Chen YG, Dishevelled. The hub of Wnt signaling. Cell Signal. 2010;22:717\u201327. https:\/\/doi.org\/10.1016\/j.cellsig.2009.11.021.","journal-title":"Cell Signal"},{"key":"873_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nsmb1247","volume":"14","author":"T Schwarz-Romond","year":"2007","unstructured":"Schwarz-Romond T, Fiedler M, Shibata N, et al. The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat Struct Mol Biol. 2007;14:484\u201392. https:\/\/doi.org\/10.1038\/nsmb1247.","journal-title":"Nat Struct Mol Biol"},{"key":"873_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cellsig.2007.10.031","volume":"20","author":"A Vlad","year":"2008","unstructured":"Vlad A, R\u00f6hrs S, Klein-Hitpass L, M\u00fcller O. The first five years of the Wnt targetome. Cell Signal. 2008;20:795\u2013802. https:\/\/doi.org\/10.1016\/j.cellsig.2007.10.031.","journal-title":"Cell Signal"},{"key":"873_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu X, Que H, Li Q, Wei X. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Mol Cancer. 2025;24:171. https:\/\/doi.org\/10.1186\/s12943-025-02363-1.","journal-title":"Mol Cancer"},{"key":"873_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/2159-8290.Cd-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta M, Bresnahan E, Molina-S\u00e1nchez P, et al. \u03b2-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. Cancer Discov. 2019;9:1124\u201341. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0074.","journal-title":"Cancer Discov"},{"key":"873_CR11","doi-asserted-by":"publisher","first-page":"2251696","DOI":"10.1080\/21655979.2023.2251696","volume":"14","author":"A Dev Jr","year":"2023","unstructured":"Dev A Jr., Vachher M, Prasad CP. \u03b2-catenin inhibitors in cancer therapeutics: intricacies and way forward. Bioengineered. 2023;14:2251696. https:\/\/doi.org\/10.1080\/21655979.2023.2251696.","journal-title":"Bioengineered"},{"key":"873_CR12","doi-asserted-by":"publisher","first-page":"eabn5683","DOI":"10.1126\/sciadv.abn5683","volume":"8","author":"M Tang","year":"2022","unstructured":"Tang M, Zhao Y, Zhao J, et al. Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes. Sci Adv. 2022;8:eabn5683. https:\/\/doi.org\/10.1126\/sciadv.abn5683.","journal-title":"Sci Adv"},{"key":"873_CR13","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.ajpath.2017.07.022","volume":"187","author":"M Yamamoto","year":"2017","unstructured":"Yamamoto M, Xin B, Watanabe K, et al. Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors. Am J Pathol. 2017;187:2711\u201325. https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.022.","journal-title":"Am J Pathol"},{"key":"873_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"C Ho","year":"2012","unstructured":"Ho C, Wang C, Mattu S, et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)\/SKP2, and c-Myc pathways. Hepatology. 2012;55:833\u201345. https:\/\/doi.org\/10.1002\/hep.24736.","journal-title":"Hepatology"},{"key":"873_CR15","doi-asserted-by":"publisher","first-page":"e110324","DOI":"10.15252\/embj.2021110324","volume":"41","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu D, Zhao J, et al. TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis. Embo j. 2022;41:e110324. https:\/\/doi.org\/10.15252\/embj.2021110324.","journal-title":"Embo j"},{"key":"873_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1349-7006.2008.00814.x","volume":"99","author":"Y Torisu","year":"2008","unstructured":"Torisu Y, Watanabe A, Nonaka A, et al. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin\/TCF. Cancer Sci. 2008;99:1139\u201346. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00814.x.","journal-title":"Cancer Sci"},{"key":"873_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/biom13040647","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Liu Y-P, Tian L-F, et al. Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt\/\u03b2-Catenin Signaling Pathway. Biomolecules. 2023;13:647.","journal-title":"Biomolecules"},{"key":"873_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.15283\/ijsc23070","volume":"16","author":"F Farnhammer","year":"2023","unstructured":"Farnhammer F, Colozza G, Kim J. RNF43 and ZNRF3 in Wnt Signaling - A Master Regulator at the Membrane. Int J Stem Cells. 2023;16:376\u201384. https:\/\/doi.org\/10.15283\/ijsc23070.","journal-title":"Int J Stem Cells"},{"key":"873_CR19","doi-asserted-by":"publisher","unstructured":"Bell I, Khan H, Stutt N, et al. Nkd1 functions downstream of Axin2 to attenuate Wnt signaling. Mol Biol Cell. 2024;35(ar93). https:\/\/doi.org\/10.1091\/mbc.E24-02-0059-T.","DOI":"10.1091\/mbc.E24-02-0059-T"},{"key":"873_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14259","volume":"519","author":"S Kakugawa","year":"2015","unstructured":"Kakugawa S, Langton PF, Zebisch M, et al. Notum deacylates Wnt proteins to suppress signalling activity. Nature. 2015;519:187\u201392. https:\/\/doi.org\/10.1038\/nature14259.","journal-title":"Nature"},{"key":"873_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-021-03525-z","volume":"594","author":"DJ Flanagan","year":"2021","unstructured":"Flanagan DJ, Pentinmikko N, Luopaj\u00e4rvi K, et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature. 2021;594:430\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03525-z.","journal-title":"Nature"},{"key":"873_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41467-021-27923-z","volume":"13","author":"G Belenguer","year":"2022","unstructured":"Belenguer G, Mastrogiovanni G, Pacini C, et al. RNF43\/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state. Nat Commun. 2022;13:334. https:\/\/doi.org\/10.1038\/s41467-021-27923-z.","journal-title":"Nat Commun"},{"key":"873_CR23","doi-asserted-by":"publisher","first-page":"e18650","DOI":"10.1371\/journal.pone.0018650","volume":"6","author":"TJ Van Raay","year":"2011","unstructured":"Van Raay TJ, Fortino NJ, Miller BW, et al. Naked1 antagonizes Wnt signaling by preventing nuclear accumulation of \u03b2-catenin. PLoS ONE. 2011;6:e18650. https:\/\/doi.org\/10.1371\/journal.pone.0018650.","journal-title":"PLoS ONE"},{"key":"873_CR24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1128\/mcb.00272-12","volume":"32","author":"KS Carmon","year":"2012","unstructured":"Carmon KS, Lin Q, Gong X, Thomas A. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt\/\u03b2-catenin signaling. Mol Cell Biol. 2012;32:2054\u201364. https:\/\/doi.org\/10.1128\/mcb.00272-12.","journal-title":"Mol Cell Biol"},{"key":"873_CR25","doi-asserted-by":"publisher","unstructured":"Cadigan KM, Waterman ML. TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol. 2012;4. https:\/\/doi.org\/10.1101\/cshperspect.a007906.","DOI":"10.1101\/cshperspect.a007906"},{"key":"873_CR26","doi-asserted-by":"publisher","first-page":"14438","DOI":"10.1074\/jbc.M109.052001","volume":"285","author":"W Qiu","year":"2010","unstructured":"Qiu W, Hu Y, Andersen TE, et al. Tumor Necrosis Factor Receptor Superfamily Member 19 (<\u2009em>TNFRSF19) Regulates Differentiation Fate of Human Mesenchymal (Stromal) Stem Cells through Canonical Wnt Signaling and C\/EBP *. J Biol Chem. 2010;285:14438\u201349. https:\/\/doi.org\/10.1074\/jbc.M109.052001.","journal-title":"J Biol Chem"},{"key":"873_CR27","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.stemcr.2021.07.007","volume":"16","author":"K Kretzschmar","year":"2021","unstructured":"Kretzschmar K, Boonekamp KE, Bleijs M, et al. Troy\/Tnfrsf19 marks epidermal cells that govern interfollicular epidermal renewal and cornification. Stem Cell Rep. 2021;16:2379\u201394. https:\/\/doi.org\/10.1016\/j.stemcr.2021.07.007.","journal-title":"Stem Cell Rep"},{"key":"873_CR28","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1073\/pnas.1519994113","volume":"113","author":"MW Kennedy","year":"2016","unstructured":"Kennedy MW, Chalamalasetty RB, Thomas S, et al. Sp5 and Sp8 recruit \u03b2-catenin and Tcf1-Lef1 to select enhancers to activate Wnt target gene transcription. Proc Natl Acad Sci U S A. 2016;113:3545\u201350. https:\/\/doi.org\/10.1073\/pnas.1519994113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"873_CR29","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1038\/s41467-024-51860-2","volume":"15","author":"W Zhao","year":"2024","unstructured":"Zhao W, Wang X, Han L, et al. SLC13A3 is a major effector downstream of activated \u03b2-catenin in liver cancer pathogenesis. Nat Commun. 2024;15:7522. https:\/\/doi.org\/10.1038\/s41467-024-51860-2.","journal-title":"Nat Commun"},{"key":"873_CR30","doi-asserted-by":"publisher","first-page":"829212","DOI":"10.3389\/fonc.2022.829212","volume":"12","author":"R Guo","year":"2022","unstructured":"Guo R, Liu T, Shasaltaneh MD, et al. Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy. Front Oncol. 2022;12:829212. https:\/\/doi.org\/10.3389\/fonc.2022.829212.","journal-title":"Front Oncol"},{"key":"873_CR31","doi-asserted-by":"publisher","unstructured":"He Q, Yang J, Jin Y. Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma. Brief Bioinform. 2022;23. https:\/\/doi.org\/10.1093\/bib\/bbac291.","DOI":"10.1093\/bib\/bbac291"},{"key":"873_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12688\/f1000research.10481.1","volume":"6","author":"A Bogdanov","year":"2017","unstructured":"Bogdanov A, Moiseenko F, Dubina M. Abnormal expression of ATP1A1 and ATP1A2 in breast cancer. F1000Res. 2017;6:10. https:\/\/doi.org\/10.12688\/f1000research.10481.1.","journal-title":"F1000Res"},{"key":"873_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-025-02322-1","volume":"11","author":"NB Tran","year":"2025","unstructured":"Tran NB, Lee SJ. Metallothionein-3-mediated intracellular zinc mediates antioxidant and anti-inflammatory responses in the complete Freund\u2019s adjuvant-induced inflammatory pain mouse model. Cell Death Discov. 2025;11:45. https:\/\/doi.org\/10.1038\/s41420-025-02322-1.","journal-title":"Cell Death Discov"},{"key":"873_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40364-024-00584-y","volume":"12","author":"MAM Rodrigo","year":"2024","unstructured":"Rodrigo MAM, Michalkova H, Jimenez AMJ, et al. Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells. Biomark Res. 2024;12:38. https:\/\/doi.org\/10.1186\/s40364-024-00584-y.","journal-title":"Biomark Res"},{"key":"873_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10863-020-09865-1","volume":"53","author":"YX Cheng","year":"2021","unstructured":"Cheng YX, Xiao L, Yang YL, et al. Collagen type VIII alpha 2 chain (COL8A2), an important component of the basement membrane of the corneal endothelium, facilitates the malignant development of glioblastoma cells via inducing EMT. J Bioenerg Biomembr. 2021;53:49\u201359. https:\/\/doi.org\/10.1007\/s10863-020-09865-1.","journal-title":"J Bioenerg Biomembr"},{"key":"873_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2976\/1.3100548","volume":"3","author":"Y Asano","year":"2009","unstructured":"Asano Y, Jim\u00e9nez-Dalmaroni A, Liverpool TB, et al. Pak3 inhibits local actin filament formation to regulate global cell polarity. Hfsp j. 2009;3:194\u2013203. https:\/\/doi.org\/10.2976\/1.3100548.","journal-title":"Hfsp j"},{"key":"873_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7150\/jca.61918","volume":"13","author":"Z Gao","year":"2022","unstructured":"Gao Z, Zhong M, Ye Z, et al. PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process. J Cancer. 2022;13:153\u201361. https:\/\/doi.org\/10.7150\/jca.61918.","journal-title":"J Cancer"},{"key":"873_CR38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/onc.2014.54","volume":"34","author":"A Feuerborn","year":"2015","unstructured":"Feuerborn A, Mathow D, Srivastava PK, Gretz N. Basonuclin-1 modulates epithelial plasticity and TGF-\u03b21-induced loss of epithelial cell integrity. Oncogene. 2015;34:1185\u201395. https:\/\/doi.org\/10.1038\/onc.2014.54.","journal-title":"Oncogene"},{"key":"873_CR39","doi-asserted-by":"publisher","unstructured":"Watts JC, Westaway D. The prion protein family: diversity, rivalry, and dysfunction. Biochim Biophys Acta Mol Basis Dis 2007;1772:654\u2013672. https:\/\/doi.org\/10.1016\/j.bbadis.2007.05.001.","DOI":"10.1016\/j.bbadis.2007.05.001"},{"key":"873_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ncb1405","volume":"8","author":"Y Funato","year":"2006","unstructured":"Funato Y, Michiue T, Asashima M, Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt\u2013\u03b2-catenin signalling through Dishevelled. Nat Cell Biol. 2006;8:501\u20138. https:\/\/doi.org\/10.1038\/ncb1405.","journal-title":"Nat Cell Biol"},{"key":"873_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00775-011-0797-4","volume":"16","author":"T Fukada","year":"2011","unstructured":"Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T. Zinc homeostasis and signaling in health and diseases. J Biol Inorg Chem. 2011;16:1123\u201334. https:\/\/doi.org\/10.1007\/s00775-011-0797-4.","journal-title":"J Biol Inorg Chem"},{"key":"873_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Reviews Clin Oncol. 2018;15:599\u2013616. https:\/\/doi.org\/10.1038\/s41571-018-0073-4.","journal-title":"Nat Reviews Clin Oncol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00873-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00873-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00873-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:04:59Z","timestamp":1789988699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00873-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00873-6","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by Institutional Review Board of Huashan Hospital (HIRB) (Approval No. KY2024-1113). Informed consent was obtained from all individual participants included in the study (or their legal guardians). All animal studies were conducted according to the ARRIVE guidelines 2.0 and were approved by The Animal Welfare and Ethical Committee of Shanghai Rat&Mouse Biotech Co.,Ltd (Shanghai, China) (Approval No. 20250304(12)).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"180"}}